EUVIMEDEUVIMED entdecken
Crossref

The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments

Thijs Van de Vyver, Cristina Muntean, Iuliia Efimova, Dmitri V Krysko, Lynn De Backer, Stefaan C De Smedt, Koen Raemdonck

Journal of Controlled Release · 2023-12 · 364 · 142-158

DOI: 10.1016/j.jconrel.2023.10.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-12. Verfasst von Thijs Van de Vyver und 6 weiteren Autor:innen. Beteiligte Einrichtung: Ghent Research Group on Nanomedicines, Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University…. Hauptthemen laut MEDLINE: Prazosin, Nanoparticles. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 118 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek Vlaanderen, European Research Council, Horizon 2020.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The widespread use of small interfering RNA (siRNA) is limited by the multiple extra- and intracellular barriers upon in vivo administration. Hence, suitable delivery systems, based on siRNA encapsulation in nanoparticles or its conjugation to targeting ligands, have been developed. Nevertheless, at the intracellular level, these state-of-the-art delivery systems still suffer from a low endosomal escape efficiency. Consequently, the bulk of the endocytosed siRNA drug rapidly accumulates in the lysosomal compartment. We recently reported that a wide variety of cationic amphiphilic drugs (CADs) can promote small nucleic acid delivery from the endolysosomal compartment into the cytosol via transient induction of lysosomal membrane permeabilization. Here, we describe the identification of alternate siRNA delivery enhancers from the NIH Clinical Compound Collection that do not have the typical physicochemical properties of CADs. Additionally, we demonstrate improved endolysosomal escape of siRNA via a cholesterol conjugate and polymeric carriers with the α1-adrenergic antagonist prazosin, which was identified as the best performing delivery enhancer from the compound screen. A more detailed assessment of the mode-of-action of prazosin suggests that a different cellular phenotype compared to typical CAD adjuvants drives cytosolic siRNA delivery. As it has been described in the literature that prazosin also induces cancer cell apoptosis and promotes antigen cross-presentation in dendritic cells, the proof-of-concept data in this work provides opportunities for the repurposing of prazosin in an anti-cancer combination strategy with siRNA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrazosinNanoparticlesRNA, Small InterferingCytosolLysosomesAdrenergic alpha-Antagonists

Stichwörter der Autor:innen

Cationic amphiphilic drugsCombination therapyDrug repurposingEndosomal escapeLysosomal membrane permeabilizationcancer immunotherapycancer therapy

Substanzen

RNA, Small InterferingPrazosinAdrenergic alpha-Antagonists

Autor:innen und Institutionen

  • Ghent Research Group on Nanomedicines, Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium. Electronic address: thi…
  • Ghent Research Group on Nanomedicines, Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium; Cancer Research Institu…
  • Cell Death Investigation and Therapy Laboratory, Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, 9000 Ghent, Belgium; Cancer Research Institute Ghent, 9000 Ghent, Bel…
  • Ghent Research Group on Nanomedicines, Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000 Ghent, Belgium. Electronic address: lyn…

Förderung

  • Fonds Wetenschappelijk Onderzoek Vlaanderen
  • European Research Council
  • Horizon 2020
  • Ghent University

Zitieren

APA

Van de Vyver, T., Muntean, C., Efimova, I., Krysko, D. V., De Backer, L., De Smedt, S. C., & Raemdonck, K. (2023). The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments. Journal of Controlled Release, 364, 142-158. https://doi.org/10.1016/j.jconrel.2023.10.014

Vancouver

Van de Vyver T, Muntean C, Efimova I, Krysko DV, De Backer L, De Smedt SC, et al. The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments. Journal of Controlled Release. 2023;364:142-158. doi:10.1016/j.jconrel.2023.10.014

BibTeX
@article{VandeVyver2023,
  author = {Van de Vyver, Thijs and Muntean, Cristina and Efimova, Iuliia and Krysko, Dmitri V and De Backer, Lynn and De Smedt, Stefaan C and Raemdonck, Koen},
  title = {The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments},
  journal = {Journal of Controlled Release},
  year = {2023},
  volume = {364},
  pages = {142--158},
  doi = {10.1016/j.jconrel.2023.10.014}
}
Kostenlos starten →